Phuwajaroanpong Arisara, Chaniad Prapaporn, Plirat Walaiporn, Konyanee Atthaphon, Septama Abdi Wira, Punsawad Chuchard
Department of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Research Center in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Adv Pharmacol Pharm Sci. 2023 Sep 15;2023:6624040. doi: 10.1155/2023/6624040. eCollection 2023.
Drug resistance remains a significant problem that threatens antimalarial drug treatment. Hence, the challenge is to find new effective antimalarial drugs. Based on our previous study, aqueous extracts of trisamo (TSM) and jatu-phala-tiga (JPT) had good antimalarial activities, and these recipes contain multiple beneficial pharmacological effects that could be useful for malaria therapy. Therefore, this study aimed to investigate the antimalarial activity and toxicity of the aqueous extracts of TSM and JPT in mouse models. The aqueous extractions were carried out using the decoction method. Compound identification was conducted using LC-QTOF-MS analysis. The antimalarial activities of TSM and JPT at doses 200, 400, and 600 mg/kg were evaluated against ANKA infection using a four-day suppressive test. The toxic effects of oral administration of the extracts at 2 g/kg dose were determined using an acute toxicity test. The chemical constituents of TSM contained 83 compounds, whereas JPT contained 84 compounds. All doses of the extracts exhibited a significant suppression ( < 0.05) of the parasite compared to the negative control in a four-day test. The maximum activities were observed at 600 mg/kg dose with 67.02% suppression for TSM and 79.34% for JPT, followed by 400 mg/kg dose (57.63% for TSM and 64.79% for JPT) and then 200 mg/kg dose (52.35% for TSM and 54.46% for JPT). In addition, there were no significant differences ( < 0.05) in the RBC, MCV, and MCH levels of mice receiving JPT extract compared to the uninfected control. The WBC level of mice receiving 400 and 600 mg/kg of TSM, and 200 and 400 mg/kg of JPT, was significantly ( < 0.05) lower than the infected control, and the extracts did not significantly prevent the loss of platelets. For the acute toxicity test, there were no signs of toxicity or deaths in mice, and there were no differences in the histology, weight, or enzyme biochemistry of the liver and kidney between the extract and vehicle groups. However, the platelet count in the extract-treated mice was significantly higher than that in the control group. In conclusion, this study suggests that aqueous extracts of TSM and JPT have potent antimalarial activities and could be promising as new candidates for antimalarial drug development.
耐药性仍然是一个严重的问题,威胁着抗疟药物治疗。因此,挑战在于找到新的有效抗疟药物。基于我们之前的研究,刺蒴麻(TSM)和印度獐牙菜(JPT)的水提取物具有良好的抗疟活性,并且这些配方含有多种有益的药理作用,可能对疟疾治疗有用。因此,本研究旨在研究TSM和JPT水提取物在小鼠模型中的抗疟活性和毒性。采用煎煮法进行水提取。使用液相色谱-四极杆飞行时间质谱(LC-QTOF-MS)分析进行化合物鉴定。采用四天抑制试验,评估TSM和JPT在200、400和600mg/kg剂量下对ANKA感染的抗疟活性。使用急性毒性试验确定以2g/kg剂量口服提取物的毒性作用。TSM的化学成分包含83种化合物,而JPT包含84种化合物。在四天试验中,与阴性对照相比,所有剂量的提取物均表现出对疟原虫的显著抑制作用(P<0.05)。在600mg/kg剂量下观察到最大活性,TSM的抑制率为67.02%,JPT为79.34%,其次是400mg/kg剂量(TSM为57.63%,JPT为64.79%),然后是200mg/kg剂量(TSM为52.35%,JPT为54.46%)。此外,与未感染对照相比,接受JPT提取物的小鼠的红细胞、平均红细胞体积和平均红细胞血红蛋白水平没有显著差异(P<0.05)。接受400和600mg/kg TSM以及200和400mg/kg JPT的小鼠的白细胞水平显著低于感染对照(P<0.05),并且提取物没有显著预防血小板损失。对于急性毒性试验,小鼠没有毒性迹象或死亡,提取物组和赋形剂组之间肝脏和肾脏的组织学、体重或酶生化没有差异。然而,提取物处理小鼠的血小板计数显著高于对照组。总之,本研究表明TSM和JPT的水提取物具有强大的抗疟活性,有望成为抗疟药物开发的新候选药物。